Length and complexity of illness and treatment in early breast cancer mean that the acute phase may extend over months. Employing concepts of "trajectory" and "work" from chronic illness, we explored the temporality of the illness experience for women as it unfolded from diagnosis through acute treatment. We performed multiple, qualitative interviews with 14 women at critical points in their first year postdiagnosis. We differentiated between subphases of the acute breast cancer trajectory: becoming a person with breast cancer: a turning point; first steps in treatment: struggling to protect self-concept; being and feeling ill: "cure" as suffering; and conditional "recovering": an uncertain future. Each subphase represented the distinctive context in which illness management took place with consequences for the work women and those close to them engaged in, to manage the practical, emotional, relational, and existential demands of an illness that intruded every aspect of their lives.
Introduction
Breast cancer is the most common cancer diagnosed in women worldwide (Jemal et al., 2011) . In England, it accounts for around one third of new cases of cancer in women and women have a one in eight chance of a breast cancer diagnosis in their lifetime (Office for National Statistics [ONS], 2012) . It affects women across the age spectrum. Nearly half of those diagnosed with breast cancer are aged 50 to 69, and it is the most commonly diagnosed cancer in young women (under 39 years). Between 1971 and 2011, the breast cancer mortality rate in England reduced by over a third despite a doubling of new cases per annum, and recent data indicate that one and five year survival rates have increased to 96% and 86% respectively (ONS, 2016) .
These changes are largely attributed to early diagnosis and improved treatments. For example, in the United Kingdom, the NHS Cancer Plan (Department of Health, 2000) introduced a two-week referral pathway from presentation of suspect symptoms to specialist diagnosis, and a maximum 31 day wait from diagnosis to first treatment for all cancers. Sequential treatments from chemotherapy through radiotherapy, biological therapies, and preventive medication extend treatment for many women over months and several years, resulting in side effects of varying type and duration. Thus the illness course and projected lifespan is longer and more variable, and the simple distinction between acute and chronic illness fails to capture the trajectory complexity (Tritter & Calnan, 2002) .
The changes to routine disease management and development of novel treatment modalities which extend the illness course pose new challenges for women. These embrace the shifting meaning attached to breast cancer over time and the work involved in sustaining "self" and managing the illness in everyday life. This article provides insight into the emergent character of early breast cancer as this unfolds in time for women through acute treatment, and the interrelated strands of "work" they engage in to simultaneously manage selves, lives, and relationships.
Background
Qualitative research on the meanings of breast cancer for women and the existential, physical, and psychosocial effects of diagnosis and treatment has expanded over 746378Q HRXXX10.1177/1049732317746378Qualitative Health ResearchGodfrey et al.
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1 University of Leeds, Leeds, UK 2 Independent Researcher, Edinburgh, Scotland three decades. Dimensions examined include the effects of changed appearance (loss of breast and hair) on body image and sexuality (Crouch & McKenzie, 2000; Harcourt & Frith, 2008; Richer & Ezer, 2002; ThomasMacLean, 2010) ; the physical and emotional sequellae of treatment (Oxlad, Wade, Hallsworth, & Koczwara, 2008) , specifically radiotherapy (Schnur, Ouellette, Bovbjerg, & Montgomery, 2009 ) and chemotherapy (Beisecker et al., 1997; Boehmke & Dickerson, 2006; McCann, Illingworth, Wengstrom, Hubbard, & Kearney, 2010) , which persist for some women long after treatment ends (McKenzie & Crouch, 2004; Thomas-MacLean, 2004; Trusson, Pilnick, & Roy, 2016) ; and the sociocultural context shaping the experience (Hammoudeh, Hogan, & Giacaman, 2017; Liamputtong & Suwankhong, 2015) . Research has also addressed existential questions of life and death which give rise to fear and anticipatory suffering, vulnerability, and threat to self (Arman & Rehnsfeldt, 2003) , although the pervasiveness of suffering is contested. Landmark and Wahl (2002) conclude that although diagnosis provokes anguish, anger, and fear, these reactions are transitory, and others report the cancer experience as "transformative" (Browall, Gaston-Johansson, & Danielson, 2006) or opportunity for positive change (Horgan, Holcombe, & Salmon, 2011 ; see also H. D. Price's [2006] review of breast cancer autobiographical narratives).
A feature of many studies is that the temporal dimension of the breast cancer experience is largely ignored. This applies at methodological and conceptual levels. Research on the impact of diagnosis and treatment on sense of self may examine this cross-sectionally with women at different illness stages (between two and 20 years in the Crouch & McKenzie studies), so that the temporal structure of the experience and change process is rendered invisible. Studies exploring the persistence of suffering have often recruited through cancer support groups (Powers, Gullifer, & Shaw, 2016; ThomasMacLean, 2004) or via national and local media (Trusson et al., 2016) , raising the possibility that participating women are those for whom the experience is an ongoing source of distress. Within this expanding literature on survivorship in breast cancer, accounts of diagnosis and treatment are conveyed often years after the event (McKenzie & Crouch, 2004; Powers et al., 2016; ThomasMacLean, 2004; Trusson et al., 2016) . Even when examined at multiple time-points following diagnosis, the change process may be captured only in large brushstrokes (from health to illness as in McCann et al., 2010) or in respect of one dimension (bodily changes in Frith, Harcourt & Fussell, 2007 ; effects of adjuvant treatment in Boehmke & Dickerson, 2006) . Understanding breast cancer within a temporal framework is critical not only to comprehend the meaning of illness and impact of treatments that affect its course, but to locate the work of managing it in dynamic relationship with the shifting character of the disease and treatment regimen, and which in turn has implications for providing appropriate and timely support.
Conceptual Framework
In framing the study, we drew on linked concepts of "trajectory" and "illness work" as developed by Strauss and colleagues from research on chronic illness (Corbin & Strauss, 1985 , 1988 . "Trajectory" refers to the temporal quality of the illness experience as this is shaped interalia by the physiological unfolding of the disease process and medical regimen, and the interrelated strands of work engaged in by those who are ill and their significant others to live with, adapt to, and manage it.
Managing chronic illness, Corbin and Strauss (1988) argued, involves three main lines of interconnected and reciprocally interactive types of "work": biographical, illness-related, and everyday life work. Biographical work is what people do to contextualize the illness into their biography, making it part of an ongoing life. It is affected by the meaning of illness, the context in which it occurs, and the resources available to the individual. Illness-related work pertains to the illness and treatment regimen, including symptoms and treatment side effects. A further line of work is managing everyday life and relationships with illness.
The nature and intensity of trajectory work will vary with illness severity, the type of trajectory, and its phasing within types, for example, whether the trajectory projection is remitting, life threatening, or deteriorating. The work of illness management then occurs in conditions which are fluctuating and changing, what they term "structure in process" to indicate its structural and dynamic character. It is the interplay between efforts to gain some control over these conditions and respond to contingencies, whether anticipated or unexpected, that affect the illness course, and which shape the phases and subphases of different trajectories.
The significance of the trajectory concept is that it directs attention on individual agency in illness adaptation albeit in conditions established by the disease process and treatment regimen. Understanding the precise phase or stage that a condition undergoes over its course is crucial to gaining an accurate picture of the associated types of work and resources to facilitate its management, and which in turn impact its meaning and consequences. Regarding early breast cancer, the trajectory concept provides a sensitizing framework to examine the temporal dimension of the experience for women, the conditions that affect it, and the consequences that flow from it, uniquely in context of the acute illness phase. It also has potential to illuminate need and supportive resources at key turning points within and through trajectory subphases.
Research Design
This article draws on multiple, qualitative interviews with women with early breast cancer. Data were collected as part of a longitudinal, intervention study to examine the theory and practice of traditional acupuncture (TA), using early breast cancer as an exemplar of a complex condition. The interview purpose was to locate the process and outcomes of acupuncture in context of women's experience over the acute breast cancer trajectory phase and to provide insight into the meaning, significance, and consequence of illness and treatment as it unfolded in time. Thus, focus extended considerably beyond perceptions of acupuncture in content and timeframe. Women were recruited from two hospitals in neighboring northern English cities, a specialist regional cancer center and a district teaching hospital, and introduced to the study via their oncologist. Ethical approval was obtained from the research ethics committee which provides ethical review of health-related research in the United Kingdom (reference: 07/HI306/79). Written consent was obtained. Methods, details of participants, and findings of acupuncture care have been reported elsewhere (S. Price, Long, & Godfrey, 2013 , 2014 .
Data Collection
In all, 35 in-depth interviews with 14 women, lasting between 50 and 120 minutes, audio-recorded and fully transcribed, were conducted across three time-points: after first line surgical treatment and 7 to 10 days before chemotherapy commenced; approximately 4 months later toward the end of chemotherapy; and around 5 months subsequently following adjuvant treatment. For resource reasons, third interviews were conducted with seven women only, purposively selected to examine variation in meaning and experience for women at different life stages and undergoing different treatment regimens. With one exception, interviews took place at two cancer support centers; one occurred in hospital. Interviews were guided conversations. The first started, "Tell me how you discovered you had breast cancer?" It then explored the impact of diagnosis and surgery; how it was understood and felt for women and those close to them in context of their lives and relationships; and anticipation of future treatment. The second began, "How have things been for you in the last few months?" It elicited accounts of chemotherapy and its consequences for their sense of self and what they could do including accessing and receiving support from family and friends. The third started, "How are things for you now?" and then probed subsequent treatments; what had changed and what remained the same. Timing of interviews facilitated near-experience accounts of what went before in vivid detail, how these shaped meaning and (inter)action in the present, and which in turn were informed by anticipated fears and hopes for the future.
Women were aged 29 to 75 years, mostly White British and varied in their socioeconomic circumstances. Although all were enmeshed in family relationships, household composition and family circumstances varied with age and life stage (Table 1) .
Data Analysis
We employed grounded theory methods in collecting and analyzing data (Charmaz, 2014) . Field notes, including observational, methodological, and reflexive notes, were made immediately after each interview. These together with fully transcribed interviews were discussed within the research team and suggested new lines of enquiry. For example, initial interviews revealed a kaleidoscope of conflicting meanings of the breast cancer experience encapsulated in the following phrase: everything and nothing had changed with the diagnosis. This directed attention on women's presentation of self to different "others," exploration of seemingly contradictory meanings and actions, how these changed over time and in relation to the unfolding illness context, for women in difference circumstances. Further phases included familiarization of the data set through multiple reading of transcripts to develop a picture of range and variability, and open coding to identify patterns with focus on the temporal sequencing of events and how these were understood. We analyzed a sample of audio interviews and transcripts independently to review the inferences and interpretations drawn from the data. At each analytic stage-development of codes, categories, concepts, and the relationships between themdiscussion within the research team occurred to further refine these through iterative reflection and perusal of the data. Privacy, anonymity, and confidentiality were upheld at all times, and pseudonyms have been used throughout.
While the "trajectory" concept offered orienting guidance in examining the empirical data (Blumer, 1969; Van den Hoonaard, 1997) , we employed methods of constant comparison and search for negative cases to examine its specific meaning in early breast cancer. We identified potentially fruitful analytic codes to pursue through focused coding and memos. For example, the "in-vivo" code "being normal" was developed as an analytical category. Comparing and contrasting accounts and incidents between individuals and over time, we explored its properties, the conditions that shaped it, the emotional and interactional strategies that sustained it, and the disease process and treatment regimen that challenged it.
Findings

The EBC Trajectory
The acute EBC trajectory comprised several subphases: becoming a person with breast cancer: a turning point; first steps in treatment: struggling to protect self-concept; being and feeling ill: "cure" as suffering; and conditional "recovering": an uncertain future. These subphases were shaped interalia by the life-threatening character of the diagnosis, the anticipated and actual illness course and treatment regimen, and the struggle to make sense of it all. Length and treatment regimen varied. Three women had a mastectomy reflecting its current more differentiated use in treating breast cancer; the rest had a lumpectomy. While everyone received chemotherapy, acute treatment was prolonged by radiotherapy for more than half of women, including three who were prescribed biological therapy (Herceptin). For most women, the phase from diagnosis to the conclusion of acute treatment lasted up to 12 months, extending over a further year for those on Herceptin infusions. Each subphase was distinctive in its meaning for participants; in its consequences for sense of self and for managing illness and daily life; in the feelings generated; and the emotion work involved in coming to terms with it for women and those close to them.
Becoming a Person With Breast Cancer: A Turning Point
Unlike most illnesses, "becoming a person with breast cancer" unfolded over the diagnostic process. The starting point of the trajectory, as recounted by women in the first interview, was the discovery of a lump in the breast. For most women, this occurred accidentally when showering or bathing; for two women the process commenced following a routine mammogram. In all cases, the "discovery" precipitated multiple and sequential medical encounters. In absence of signs of illness, women listened and looked for verbal and nonverbal cues from medical professionals as to what might be going on, eschewing direct questions, anticipating and fearing the certainty of a cancer diagnosis. The speed of referral from general practitioner to hospital was the first intimation that it might be serious. Then successive investigations-mammogram, ultrasound, and biopsy-ratcheted up women's anxiety, being "read" as cumulative evidence of their worst fears being realized.
The GP didn't say a lot actually; she felt it and said: "yes there is something" . . . I just thought she might say: oh a lot of these things are benign. But she didn't say anything . . . just that it needed to get checked . . . which . . . bothered me . . . A week later I got an appointment . . . So it's all a waiting game right from the beginning . . . Everything seems to take so long (sighs) although it's not in reality. Although in elapsed time, the diagnostic process was completed within a short timeframe (several weeks), it felt protracted and lengthy.
In this interview, women wept as they talked of their pain on being told they had breast cancer. Similar to others (Evans, Tulsky, Back, & Arnold, 2006; Walsh & Nelson, 2003) , communication of the formal diagnosis was perceived as a pivotal and defining moment in their biography. Time, place, and context of diagnosis were conveyed in vivid detail, reinforcing the meaning of the cancer diagnosis as constituting a turning point or "critical situation," in which "the structures of everyday life and the forms of knowledge which underpin them are disrupted" (Bury, 1982, p. 169) . The short time between diagnosis and surgery-approximately two weeks-was a period of intense emotionality as women's fears bubbled up in uncontrollable tears. While they perceived the diagnosis as irrevocably altering their sense of themselves, its consequences for how they experienced their bodies and for what they could do, was in the future. In this respect, the body had not yet become a site of illness. Rather, the incongruity between the trajectory projection of a potentially life-threatening illness and the fact that they did not feel ill contributed to the maelstrom of emotions-shock, devastation, and disbelief-experienced.
I wasn't ill, that's the thing; when I went to hospital to have surgery . . . I was in perfect health. The knowledge that cancer was growing inside unbeknownst to them provoked confusion and anger: at the failure of the body to signify impending threat and that they had taken it for granted.
Relational Impact of Cancer
Women's diagnostic journey occurred relationally in that everyone was accompanied to investigations and subsequent medical appointments by someone close, typically a partner, adult daughter, sister, or parent. Embedded in intimate and personal relationships with partners, children, siblings, parents, and friends, women acknowledged that the illness would affect these significant others in its portent of loss and meaning for a shared future. Nevertheless, the process whereby women sought practical and emotional support, and to whom they communicated emotions and needs was affected by not wanting to impose an undue burden, and was negotiated within broad normative constraints. Whereas practical assistance was drawn from a wide circle, the nature of the relationship set the parameters around who women perceived as appropriate to share fears and distress. Partners/ spouses were viewed as primary confidantes and sources of emotional support. Women were more circumspect about disclosing vulnerability to adult children seen as reversing the natural order of the relationship. One woman said, "my partner gets more of my being scared" whereas her adult daughter, with whom she was very close, did not, "because I am her Mum . . . I'm the strong one." Contextual factors challenged such relational assumptions. Women were ambivalent about seeking emotional support from adult children, not wanting to "give the pain to them." Where the relationship was close and women felt a need for someone to "hear" and "interpret" what medical professionals were saying, they involved them in medical encounters. In contrast, a young women still living at home regarded her mother as her primary confidante and a source of strength.
Even as they drew on emotional support from significant others, protecting them from aspects of illness burden shaped how and to what extent details of the illness were conveyed. One woman's husband went with her to all out-patient appointments. Following the lumpectomy, she purposively went alone for the results, fearing bad news.
I spared [him] that . . . I thought I'd rather go home, sit him down, and tell him myself, because he would have been devastated listening to the doctors saying that the breast has got to come off. I don't think he'd be able to live with that really.
(Participant 06, 51-60 years)
There were also those significant others deemed "vulnerable" and with whom the diagnosis was not shared, because of a desire to protect them, for example aged parents: what would be the point; they would only worry.
First Steps in Treatment: Struggling to Protect Self-Concept
During this subphase spanning surgery and its immediate aftermath, women conveyed a rollercoaster of emotions. Even as they described the cancer diagnosis as cataclysmic and life changing and had just gone through appearance changing surgery, women, in this first interview, presented their self-concept as unchanged. Surgery had excised the cancer. They were their "normal" selves, not defined as cancer "victims" ("being normal"), working at resuming their everyday routines ("doing normal"), and supported by close family and friends in being cared about and not cared for ("relating normal"). Nevertheless, the disparity between their presentation of selves and lives as "normal" or at most of having undergone a temporary change was belied by the rawness of their emotion, their inability to control its expression, and the weight of the emotional work to sustain hope of recovery.
"Doing normal."
In the immediate aftermath of surgery, women reluctantly accepted help from family with daily life routines as a consequence of pain, reduced movement, and fatigue. Where partners assumed most of the household tasks postsurgery, within weeks there was a gradual shift back to their usual pattern. Women who prior to diagnosis were in employment, anticipated that they would resume work in the foreseeable future. Conveying need for help as temporary and that "normal" life would resume in time was supportive of a construction of self as unchanged. For several women, contingencies such as need for further surgery or complications that extended the period of recovery, challenged but did not fundamentally alter their presentation of self as "normal."
Even so, the cancer diagnosis invested new meaning for women in seeking out and accepting practical and emotional support from significant others. This was presented simultaneously as recognizing the need for, and ambivalence about receiving help:
I'm used to doing an awful lot on my own . . . I have let people into this . . . including my partner . . . more than I've done before . . . . When you're not used to asking for help, it's quite hard to do it.
(Participant 03, 41-50 years)
Women were distressed about needing to be "looked after." Their primary anticipatory fear regarding chemotherapy was prolonged dependence on others. Foreshadowed nausea, sickness, tiredness/fatigue, and pain were viewed as a threat to resuming "doing normal." I can cope with pain and surgery and fighting back and getting fit again but I can't bear feeling . . . so unwell during chemo that I can't get on with my life. (Participant 11, (61) (62) (63) (64) (65) (66) (67) (68) (69) (70) At the same time, they talked of getting on with chemotherapy, willing to try anything that might help and downplayed its potential impact on appearance. In contrast to other studies which report anticipation of hair loss as among the most common, feared consequences of chemotherapy, particularly among younger women (Frith, Harcourt, & Fussell, 2007) , the pattern here was variable. Both older and younger women asserted that they were unconcerned about hair loss. Those who anticipated hair loss as worrisome referred to its significance as a visible marker of "cancer victimhood" to the external world; they hoped to avoid it with "cold cap" treatment.
"Relating normal." Women emphasized the value attached to family and friends relating to them as if nothing had changed. One woman noted that her family "don't walk on egg shells around me, which is good"; and another's partner had "found the right balance" by being supportive "in a discreet way." Some were explicit about how they wanted others to act toward them as, When I told relatives they was shocked and started to look sad and, you know, crying, and I says: look I do not want anyone around me who is weeping . . . if you are coming to see me, you cry before you come or you cry after you've seen me . . . I want just positive people around me . . . so they stuck to that.
They acknowledged that relating to them as "normal" did not mean that significant others were unaffected emotionally. Several women spoke of being aware that partners and close relatives "did their share of crying" alone (as they did), as they reassured those others that they themselves were "fine." One participant described catching her younger brother sat in the kitchen crying and she wanted to hug and reassure him. She felt her mother was "coping quite well . . . with me . . . I suspect when she is on her own, she is being, you know (long pause) different." "Relating normal" then involved a level of mutual and reciprocal suppression of distress, albeit in an open awareness context.
"Being normal."
Women's presentation of "doing" and "relating" normal were contributory to, and reinforcing of, their self-concept as unchanged. The work of reinforcing the "normal" selfincluded talking about "ordinary" things and avoiding situations in which others acted toward them as if they were "different." Yet, this assertion of "being normal" could not be read off unproblematically from women's talk. It was intertwined with what they wanted to be: Working at "normal": Emotion work. For women during this subphase, sustaining "normal" with regard to selfconcept and in their relationships with significant others involved considerable work. This was directed at managing the maelstrom of emotions flowing from their fears of an uncertain future, awareness of the distress of close others, and their desire to protect them, as significant others also sought to protect them.
Women conveyed in their talk that they had to keep positive "to beat the cancer." It was what was expected of them to actively manage their illness; it would also likely improve their chance of recovery. But keeping positive did not guarantee recovery: It was also hard work:
I'm trying [to be positive] I've struggled with it but at least it is another of those things that I feel like I am trying to do something for myself . . . but you would be a fool to say it doesn't get to you . . . but then there is nothing definitive in what your life is going to be . . . so you get on with it and make the best out of it.
(Participant 04, 41-50 years)
Being positive was work in relation, in that women enjoined significant others in a reciprocal, mutual endeavor directed at regulating intense emotions to promote positivity-even if they did not unambiguously embrace it. The downside of work to keep positive was that open expression of distress was muted and deepest fears were hesitantly, if partially, shared with significant others, echoing research conducted with caregivers (Lindholm, Rehnsfeldt, Arman, & Hamrin, 2002) . There were costs then to "keeping positive" and the benefits in reducing uncertainty were not secure.
These conflicting and chaotic accounts during this subphase reflected women's emotional turmoil and doubts about an anticipated future, even as they conveyed disruption to their daily lives as temporary and their sense of self as unchanged. Within the same interview, they questioned whether the cancer had been excised; embraced chemotherapy as a necessary tool in the medical armory to take and keep the cancer away; anticipated side effects as "grim"; and reckoned treatment was time limited.
Being and Feeling Ill: "Cure" as Suffering
The second interview occurred before the final chemotherapy cycle. The start of lengthy adjuvant treatments marked this subphase. With one exception, women experienced the physical reality of illness which affected every aspect of their lives, rupturing narratives of "normal."
Normality disrupted. For most women, manifestation of illness during adjuvant treatment exceeded their worst fears. The cumulative impact of multiple and varied effects of chemotherapy-nausea, fatigue, mouth ulcers, constipation, night sweats, feeling bloated, and lack of sleep-punctured their attempts to present lives and selves as "normal." They found it difficult to convey a coherent picture of what "being ill" was like because "it changes so much of your body."
That frightened me to death . . . and feeling so helpless.
The rhythm of the chemotherapy regimen meant that the intensity of "being ill" ebbed and surged over each treatment cycle. Its lengthy duration, extending over six cycles, resulted in treatment and its effects dominating their lives; it was lost time. During the three weeks between treatments You change so much from being so ill to almost being well again and then to being ill the next day and it fluctuates so much that you can hardly remember how you felt. Then it starts again . . . and one of the worst things is taking yourself to have it done because you know it is going to make you so ill and watching it going in.
Many spoke of a disabling fatigue which was like nothing they had ever experienced. It was an all-encompassing tiredness that neither resulted from activity nor productive work and which sleep did not touch. The lassitude and whole body torpor was exacerbated by night sweats which also contributed to disturbed sleep. However much women valued "doing normal," it wasn't sustainable: They relied on family to assume most routine daily life tasks.
Being dependent on significant others was felt as a diminution in self-image:
I feel like another person. I felt like I'd lost me. I'd disappeared somewhere. The "me" that is confident and independent and gets on with stuff had disappeared into this timid little person who was completely dependent on [partner] to sort things out for me. And . . . that was difficult because that wasn't me. And I couldn't figure out where I had gone.
They looked different-to themselves and others. They mourned their changed appearance including those who made light of it at first interview.
Yeah the chemo has brought me down a lot, not just my strength. I don't like to see myself in the mirror. I think I look horrible . . . I am weak and tired and ugly.
(Participant 14, 71-80 years)
One of the two women who had a mastectomy initially downplayed loss of her breast: It served no useful function as she'd had her children. Now she felt part of her was gone, like losing a limb, with additionally feeling unattractive to her husband: "my self-esteem has hit rock bottom."
Their need for emotional support while protecting significant others from their pain, exacerbated women's distress:
You don't want to appear ill in front of the family; you don't want the family to know how bad it is. But you can't help it [weeps gently]. Despite their best efforts, "doing," "relating," and "being" normal were impossible to sustain. Even as they expressed hope that "being ill" was a consequence of treatment, and that their changed appearance would reverse in time, resumption of "normal" was tinged with uncertainty. For several women, experience of a pivotal contingency or sets of contingencies reduced or extinguished all hope of resumption of "normal." One woman reacted badly to the first chemotherapy cycle and then suffered a stroke resulting in interruption of treatment and total reliance on her daughter. Whereas in the first interview she had described multiple health problems from which "she bounced back . . . just got on with it," she now despaired at her dependence, mourned loss of an active life, and feared a future marked by deterioration.
Continuity of "normal." Some women asserted that their journey through treatment was "no big deal." For one woman, this reflected reality. Uniquely among participants although her hair thinned, she didn't lose it, and apart from the odd day feeling "off," she described sailing through treatments:
I've never been ill; I've never looked ill . . . and I've carried on doing all the housework and driving . . . and just a bit of time off work.
(Participant 02, 41-50 years)
The congruity between "being" and "doing" normal sustained her sense of an unchanged self. Nevertheless, fear of the cancer recurring was an ongoing presence; emotionality persisted as did the work of protecting her family from her distress. Other women here, conveyed life as "normal," although their contradictory narratives of "being ill" belied such accounting.
At the beginning of the second interview, one such woman commented that she had experienced no strong chemotherapy side-effects. Later, she described fatigue in vivid terms, distressing in its impact and with consequences for what she could do. Her body was being "drained and literally just walking around the house, when it is at its worst, is an effort." She tried and failed to work through it. Stretching herself physically to sustain "doing" normal in the home, she rarely went out alone, fearing being overcome by fatigue.
Another similarly played down "feeling ill" while describing night sweats and disrupted sleep that were at the most debilitating end of the spectrum. Several factors in dynamic relationship contributed to "normalizing" illness for these women during treatment. They struggled to remain strong, construed as "not being emotional" so as to keep positive and not succumb to negativity. This in turn required that they convey to close others that everything was well. However, identity claims around "being" and "doing" normal and downplaying the physical and emotional impact of illness had the effect of reducing access to relational support. For some of these women, the effort of holding on to "normal" despite the effects of illness was only sustained by maintaining a level of social and emotional distance from significant others. This extended to closing themselves off from professional support and from other patients during treatment sessions at hospital out-patients: face in a book and ears plugged to music, they blocked out sight and sound of patients and staff.
Others here employed the strategy of social comparison to normalize symptoms, seeing themselves as not suffering as badly as other women they knew. One woman, for example, who similarly underplayed the effects of chemotherapy, also described multiple physical symptoms in every part of her body: mouth, stomach, bones, appearance. Comparing her experience with that of three friends whom she met when having surgery and who provided mutual support to each other, they suffered more than she. Even so, although she presented as carrying on as normal through treatment, she was explicit that every facet of her life was uncertain: Conditional "recovering: An uncertain future." Third interviews were conducted approximately 11/12 months following diagnosis, at which point only two of the seven women interviewed had completed adjuvant treatment. Three others had started 5 years preventive hormonal medication (Arimidex and Tamoxifen respectively), and two women were beginning 12 months hospital-based biological therapy (Herceptin) involving three weekly infusions, alongside Tamoxifen. Although illness and daily life work varied with their medical regimen, in contrast to previous interviews, all of them considered that life had changed irrevocably, albeit the precise lines of demarcation of continuity and discontinuity were not fully drawn.
"Another year out of my life." For women undergoing acute treatment, "illness" work continued. Alongside persistent pain and fatigue, new treatments produced different adverse effects, for example, joint pains from combined biological therapies, and "all engulfing" hot flushes mimicking menopausal symptoms commencing with Tamoxifen. Old and new symptoms were cumulative in their physical impact, while the biological therapy regimen affected the rhythm of daily life. Even so, they resumed some valued routines (for example, taking children to school; meeting friends), albeit requiring ongoing assistance with practical tasks. As sequential treatments stretched into the distance, the continued presence of cancer work engendered an overall weariness and sense of loss for women at "another year out of my life." Conflicting self-concepts, "not looking like me but feeling like me," exacerbated the disparity between appearance and experience. There was fear that however supportive close others, they were tiring of living with the cancer, conveying that women should move beyond being a patient. Yet, they felt as "patients" whose lives were affected by illness and the acute treatment regimen. Further, the shape of recovery was unknown, although there was discontinuity with life before breast cancer.
Resuming "normal"?. Most women who had completed acute treatment talked about experiencing a gradual shift toward recovering physical health. Pain and discomfort from treatment was receding, and their presentation of self to the external world could pass as "healthy" as their hair grew back and other visible effects of adjuvant treatment (mouth ulcers, blotchy, dry skin) reduced. Yet "normal" had not resumed.
In contrast to previous subphases when their expectation of recovery as "comeback" to their prediagnosis selves, their reference point for assessing "normal" was how they felt during treatment; not how they were prediagnosis: I've settled really back to waking [in the night] three or four times . . . but unlike with chemotherapy being awake for several hours, I'm not staying awake so I've come to accept that as normal for me. Despite reestablishing a pattern of daily life routines, elapsed time increased the chasm between the person they were before and now, and they conveyed a sense of disjuncture between their previous and current lives. In part, this reflected the impact of illness time on significant life stage transitions.
Even as illness and its management seemed to collapse time, women's social world had not stood still. For those who were planning to retire, illness meant that they missed the symbolic markers of an orderly transition from work (for example, the "leaving do") so that it felt unreal. For women in the later years of paid working lives and who had regarded work as a valued source of selfworth, illness precipitated early retirement, a permanent disruption in life routines. One woman's account illustrates the interplay between time and altered social worlds:
I held on to thinking that life will be as normal. I will get through this and I will go back to work and we will carry on as we did before this happened. But . . . I came to the decision that no, life isn't going to be the same. I've handed my notice in, and we are going to do lots of things, without work coming into it . . . I didn't want to give it up . . . it was a big part of my life but I'd gone back . . . and it didn't have that same pull . . . It felt different, a lot of new faces, and I thought did I really want to come back and start again. Among older women, illness contributed to a reappraisal of them as "old": was it chronological age that explained being poorly and not the cancer? One woman expressed it as follows: I don't think I will even be back to the way I used to be with the stiffness and tiredness . . . is it getting old? It's over a year since this first happened and it's added a year on to my life so maybe it is part of getting old as well . . . . I get annoyed with the way I am because I'm slower and it's difficult to relate to that because I shouldn't think of 63 as being old.
Participant 11, 61-70 years) As well as "doing" different, a key aspect of "being" different from before was the shift that had taken place in their future orientation. Now, they articulated hesitancy about looking too far ahead. The failure of the body to signify life-threatening illness, which was a source of worry after diagnosis, moved center stage. Every pain, lump, and discomfort assumed new meaning when appraised through the cancer lens: is it indicative of cancer?
Although ontological insecurity touched everyone, the nature of their cancer experience shaped its depth and pervasiveness. At one end of the spectrum was a woman who alone among those interviewed resumed previous life routines, returning to work after treatment. She spoke of heightened sensitivity to aches and pains that might indicate cancer, yet felt optimistic about the future and was planning to move to a more expensive house. At the opposite end of the spectrum were women whose insecurity was exacerbated on account of unanticipated contingencies. Shortly after completing chemotherapy, the sister of one participant, who had provided practical and emotional support, was diagnosed with, and died of lung cancer within 4 months. She described feeling bereft as a consequence, hated her body and fear of the cancer returning was ever present.
I go to bed thinking it's going to come somewhere else . . . especially when my sister died. And my partner . . . he gets it. He will say: "I'm not going to lose you . . . don't think like that." But I do. I don't know why he is still here. I keep pushing him away. But he says I'm not going anywhere.
(Participant 05, 41-50 years)
Between these extremes, women, who because of multiple treatments or the nature of their cancer and severity of treatment effects, were more circumspect about thinking too far into the future. Several recounted being told that their tumor was "aggressive" around the time of their diagnosis and continued to ruminate on these words. For them, the possibility of cancer returning was not a generalized fear, it was a real possibility, and contributed to continued emotionality.
During the interview, women wept quietly as they reflected back on their experience. Several commented that the interview allowed them to express emotions that they felt unable to do with close others, not wanting "to upset or burden them or show your vulnerability." Even those who reported ongoing emotional support from significant others felt unable to fully share their future uncertainty.
I can't say that with certainty now [where life will take me] . . . whereas 12 months ago I would have said yes . . . I try not to think about it too much. My husband, he won't hear of it [cancer coming back] you are going to be fine and that is the end of it . . . So there is no point in pursuing it . . . it may upset him as well so I wouldn't want to. And it's the same with friends . . . I don't discuss it with them.
(Participant 09. 51-60 years)
Women reprised the changes in their lives as a consequence of cancer with a mixture of pain for what they had lost; pleasure in renewed value in the significance of personal relationships and having time for themselves; and trepidation in face of an uncertain future. Their overall presentation was that renegotiating recovery was a work in progress; they still inhabited a liminal space between illness and health (Little, Jordens, Paul, Montgomery, & Philipson, 1998) .
Discussion and Conclusions
Although the acute stage of breast cancer tends to extend considerably beyond in-hospital care, the temporality of the illness experience as this unfolds over time has not been explored in depth. We drew on concepts of "trajectory" and "illness work" developed from research on chronic illness to examine how women made sense of, lived with, and managed lives, relationships, and sense of self with breast cancer over the acute trajectory phase. We also elected to convey women's accounts in the temporal order in which they were produced, so that the messiness and chaos experienced particularly in the early subphases of the acute trajectory were visible.
For women in this study, the acute breast cancer trajectory comprised of several subphases. Each subphase represented the distinctive context in which illness management took place and required work on the part of women and significant others to manage the practical, emotional, relational, and existential demands of an illness that intruded every aspect of their lives.
The distinctiveness of early breast cancer, in comparison with other acute and chronic conditions, was that it was revealed as an "illness" through a sequence of diagnostic tests. The first subphase "becoming a person with breast cancer" involved a journey characterized by its speed and multiple encounters with medical professionals in which the probability of a cancer diagnosis increased with each successive diagnostic procedure. The sense of rupture of lives and selves consequent on the formal naming of the illness as cancer related to their appraisal of cancer as a life threat. Unlike Blow et al.'s (2011) findings, diagnosis did not begin a process of acceptance of breast cancer. Each subsequent trajectory subphase opened up new sources of uncertainty about the trajectory projection and schema pertinent to disease stage and treatment and involved the development of strategies to actively manage the illness.
The presentation of selves and lives as "normal" following surgical treatment and subsequently, coexisted with a profound sense of disruption. Differentiating between "doing," "relating," and "being" normal highlighted the work engaged in by women in different acute subphases to sustain hope in the possibility of recovery. It provided insight into the way in which the structural and dynamic character of the illness and treatment regimen ("structure in process") affected the extent to which women were able to maintain continuity with their behavioral, emotional, relational, and embodied selves. It enabled exploration of the dissonance between women's experience of early breast cancer and their presentation or narratives of it to understand the context in which such accounts are formed (Bury, 2001; Reissman, 2015) .
For women in our study, performance of "normal" in the sense of "doing" and "relating" normal was a preeminent thread in protecting their sense of self as they proceeded through the first steps in treatment. It did not denote denial of the cancer diagnosis, but was supportive of, and a means of taking control of recovery. In this, women expressed and conveyed common sociocultural understandings of cancer: that they had to share responsibility in managing the illness and that "beating the cancer" required a positive stance. The cultural dominance of these understandings has been demonstrated through multiple routes: in representations of cancer in the media (Clarke & Everest, 2006; Seale, 2001) ; as extolled in biomedical and professional discourse (Davis, 2008) ; as a moral imperative (De Raeve, 1997) and as a focus of a particular style of research (Wilkinson & Kitzinger, 2000) .
It was the struggle to sustain positivity that informed the emotion work which assumed such significance across the acute trajectory, albeit taking different forms in each subphase. For women and significant others, the diagnosis of cancer and changes in lives, relationships, and sense of self wrought by the life threat resulted in intense emotion-fear, distress, sadness, actual and anticipatory loss. Open expression of emotion by women and "significant others" threatened to dent the appearance of positivity. Presenting as "strong" and suppressing "vulnerability" involved considerable work, not only by women, but by close family and friends. Emotion work took explicit form where women enjoined close others to be "positive": "you do your crying before or after you come to see me." More commonly, there existed a shared, unspoken understanding that emotion work was a reciprocal process.
There is an uneasy fit between the nature of emotion work here and Hochschild's (1983) theory of emotional work, emotional labor, and emotion management. Seeking to explain how expression of feelings are no less orderly and shaped by social rules as behavior and action, Hochschild distinguishes between emotional labor as the management of feeling to create a "publicly observable facial and bodily display" and emotional work, to the same acts carried out in the private sphere. In both spheres, emotion management is what people do to regulate their own emotions in ways that are judged appropriate to the situation; most research focusing on emotional labor.
In context of early breast cancer, several features of emotion work that women (and close others) engaged in suggest that application of "feeling rules" neither captures the depth of the conflicting emotions women were struggling with, nor the complexity of the work involved. First, women were simultaneously grappling with multiple and contradictory emotions which were deeply felt. Although emotion management was directed interactively at enhancing the positive, distress and loss found expression when alone. Second, women's heightened emotionality meant that feelings bubbled up uncontrollably which in turn threatened to undermine the work on, for, and with close others to convey positivity. The conception of rationality and control underpinning the operation of feeling rules sits uneasily with this kind of emotion work. Third, emotion work was a reciprocal and mutual endeavor involving women and significant others; it was work in relation on and for selves vis a vis others. Significant others were not only mobilized to support the work of "normalization" to sustain positivity but they also embraced it.
Other studies of cancer have referred to the process of "normalization" or "normalizing" patient experience of illness. Hilton (1996) from interviews with families and women with early breast cancer, conceptualized "normalization" as both a style of coping and a marker of recovery such that "getting back to normal" and resuming everyday life was "putting the cancer behind them." Normalization strategies included minimizing disruptiveness, de-emphasizing or minimizing role changes and demands, and reframing negatives to be more positive. "Getting back to normal" was perceived as possible in context of the acute nature of early breast cancer; illness had an end point when treatment effects subsided. Further, "normalization" was reported as most effective where symptoms had less impact and were less intrusive, so that maintaining or resuming "normal" patterns were possible. The findings primarily conveyed the voices of family members, perhaps contributing to the conception of "normalization" as being the end of the acute phase and point of recovery. Similarly, in their study of wives of patients with prostate cancer, Williams, Hicks, Chang, Connor & Maliski (2014) considered that the "normalization" narrative conveyed by wives was an expression of "benevolent concealment": Women underplayed their own distress, engaging with their spouses' problems and not their own. They concluded that "normalization" pursued by wives conferred dis-benefits for them.
Although our study only involved interviews with women, significant others were visible as key characters in the acute breast cancer trajectory, implicated in, and contributing to, the different lines of work involved. Even as the trajectory was experienced as a relational enterprise, women kept their deepest fears and future uncertainty to themselves not wanting to burden close family and friends. They also acknowledged that close others were similarly engaged in reciprocal protection, a process that Lindholm et al. (2002) , focusing on the dis-benefits, referred to as the "vicious circle of mutual protection" (p. 251). What these different studies point to is the need to explore the reciprocal nature of cancer "illness" work and the relative benefits and dis-benefits over different trajectory phases.
Closer scrutiny of the work to sustain "normal" highlights the need to go beyond individual narratives to locate them in context and purpose (Bury, 2001 ). Women's accounts of "doing," "relating," and "being" normal in this research suggested different purposes (and associated work) at different subphases of the acute trajectory. Moreover, although these dimensions of normalization were interrelated, disruption to usual activities for example could be rationalized as temporary and one's self-concept as unchanged sustained, that is, "normalization" assumed nonlinear and interactive forms. It was shaped by the contingencies of the illness and treatment regimen, and their impact over time on women and significant others. It involved costs as well as benefits (Knafl & Deatrick, 1986; Robinson, 1993) . For some women, the struggle to sustain hope by holding on to "doing" and "relating" normal contributed to tensions in close relationships, increasing their isolation and sense of being unsupported. There were also intimations that women were ambiguous about "normalization" and "keeping positive" as effective in securing recovery. For most women, there were significant turning points. The narrative of "normal" broke down during adjuvant treatment: "doing" and "being" normal were unsustainable with intrusive symptoms. This also placed at risk "relating" as normal with significant others: Women did not want to burden them with their pain and fears for the future. The conclusion of treatment represented another turning point. Women's sense of self had altered; with one exception, they were still in process of "becoming" and recovery was incomplete.
The concept of "uncertainty" has emerged as a key theme in the breast cancer survivorship literature (McKenzie & Crouch, 2004; Powers et al., 2016; ThomasMacLean, 2004; Trusson et al., 2016) . Theories of uncertainty in illness, particularly drawing on broader psychological theories (Mishel, 1988 (Mishel, , 1990 (Mishel, , 1997 , have been subject of considerable research interest. Thus, Mishel defines uncertainty as the inability to attribute meaning to illness-related events and to accurately predict outcomes on account of disease complexity, poor information, and the unpredictability or ambiguity of such events. Uncertainty then is embedded in illness events that have those characteristics. She argues that uncertainty is a neutral cognitive state and it is the person's appraisal and response to uncertainty that mediates its impact. Although the distinction between uncertainty as a cognitive state and how it is appraised is a useful heuristic, it is difficult to differentiate them in practice. Thus, the sense of rupture of lives and selves consequent on the formal naming of the illness as cancer related to women's appraisal of cancer as a life threat.
In this study, uncertainty regarding the nature of their illness and the future featured over the whole acute trajectory, although the sources of uncertainty and how these were appraised and responded to varied between subphases. At each subphase, women anticipated new challenges arising as they simultaneously sought to manage the immediate lived demands of illness and impact of treatment for a condition that posed a future life threat. The primary strategy they adopted in the early trajectory subphases was controlling negative emotions-"being," "doing," and "relating" normal to sustain positivity. They tended to downplay current and anticipatory fears as the diagnosis challenged what was taken-for-granted in terms of an ongoing life. The struggle to maintain some control over lives and selves in conditions of emotional turmoil also contributed to the difficulties experienced in seeking out and accepting support (formal and informal). Although seeking information, particularly "expert" information, has been identified as a primary means for reducing uncertainty (Mishel, 1988) , for women here in context of breast cancer it assumed less importance. In part, this reflected their perception of the unpredictability of an illness that varied in its intrusiveness when diagnosed, in the responsiveness of individuals to treatment, and in the severity of symptoms experienced. They distrusted certainty even as they hoped for it. For women who had completed treatment, the meaning and significance of "uncertainty" varied with their experience of illness and their conception of the trajectory projection-from a generalized anxiety about recurrence to more specific assessment of actual risk for individuals.
An important feature of the study was the methodology adopted: multiple qualitative interviews aimed at providing a contemporaneous account of the emergent meaning of the illness and the associated work of managing it as these evolved in time. This meant we were able to access emotions and experience close to the events to which they pertained and which gave rise to them and draw out deeper understanding of the process of the impact and coping with breast cancer in context of women's everyday lifeworld. Even so, the length and complexity of the acute trajectory meant that more than 12 months following diagnosis, several women were entering a new phase of acute treatment and most of the remainder was prescribed preventive medication. Exploration of the acute trajectory in its entirety therefore represents a major research gap.
The study has several implications for practice. It draws attention to variation in the needs and concerns of women across different subphases of the acute breast cancer trajectory, particularly given the speed of diagnosis and commencement of treatment. While specific subphases (diagnosis and adjuvant therapy) are recognized as "turning points" for resource investment, these are also the subphases during which women experience heightened emotionality simultaneously with "keeping positive" and which make it difficult for them to reach out and receive emotional help. During these subphases, peer support from women who have gone through the experience may be more acceptable. Our findings suggest that during the immediate posttreatment period when women are beginning to come to terms with the changes in their lives as a consequence of a cancer diagnosis, they may be more open to accepting support. Yet this is often when services and support withdraw. Finally, for professionals, our study points to the significance of seeing and working with the person with cancer and their significant others relationally; although managing the complexity of processes of mutual protection in context of a perceived life threat requires particular sensitivities and skill.
Limitations
The study was conducted among a small sample of women. Intended to elicit understanding of the acute breast cancer trajectory, this was not fully accomplished. The variability of the treatment regimen meant that over 12 months we could not explore the totality of the acute phase for all participants. It is possible that following through the acute trajectory to the end would have required further elaboration and refinement of its subphases. The third set of interviews was carried out only with a subsample. Although these were selected theoretically to explore the impact of different treatment regimens and life stages on meaning and action, the findings posed new questions we were unable to answer, for example, the reciprocal relationship between a lifethreatening illness and self-concept as "old."
Other aspects of the findings provide clues about the impact of different sets of contingencies on the overall trajectory projection, for example those relating to the disease course and treatment response. For example, it is possible that one participant's negative reaction to treatment, her multiple comorbidities, and subsequent stroke initiated an unstable, deteriorating, or dying trajectory phase. How such a shift between trajectory phases might have impacted on meaning, action, and interaction would offer insight into the process of transition over the breast cancer trajectory as a whole with implications for theoretical understanding and practice. Similarly, another set of contingencies with likely impact on the experience and management of illness are major changes in social relationships and networks. Although research suggests little change in relationship status as a consequence of cancer, the impact of the dis-benefits of "normalization" and the "vicious circle of mutual protection" on relationships requires further study.
